iRhythm Holdings, Inc.(IRTC)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

iRhythm Holdings, Inc. (IRTC) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores IRTC at 54.8/100 on a 32-signal composite quality model, placing it at rank #1,297 of 2,962 stocks — the top half of the AI-ranked universe. IRTC scores in the top quartile across earnings quality (97.4), revenue growth (84.4). Areas of concern include balance sheet strength (30.3) and institutional flow (33.1), which score below median versus the broader universe. Shareholder dilution risk is elevated at 14.6/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), iRhythm Holdings, Inc. reports quarterly revenue of $224.2M, net income of $-381.0K, an operating margin of -1.1%. Top institutional holders of IRTC by reported 13-F value include BlackRock, RTW INVESTMENTS, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. IRTC trades on the Nasdaq exchange and files with the SEC under CIK 1388658. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate IRTC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for iRhythm Holdings, Inc. directly from SEC EDGAR.